Страна: Ирландия
Език: английски
Източник: HPRA (Health Products Regulatory Authority)
PROCAINE BENZYLPENICILLIN, STREPTOMYCIN SULFATE, NEOMYCIN SULFATE, PREDNISOLONE
Norbrook Laboratories Limited
QJ51RV01
PROCAINE BENZYLPENICILLIN, STREPTOMYCIN SULFATE, NEOMYCIN SULFATE, PREDNISOLONE
100,000 International Unit
intramammary Suspension
POM
Bovine
Antibacterials and corticosteroids
Antibacterial
Authorised
1988-10-01
IRISH MEDICINES BOARD ACT 1995 EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (NO. 2) REGULATIONS 2007 (S.I. NO. 786 OF 2007) VPA: 10999/006/001 Case No: 7004600 The Irish Medicines Board in exercise of the powers conferred on it by Animal Remedies (No. 2) Regulations (S.I. No. 786 of 2007) hereby grants to: NORBROOK LABORATORIES LIMITED STATION WORKS, NEWRY, CO. DOWN BT35 6JP an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the Veterinary Medicinal Product: MULTIJECT IMM INTRAMAMMARY SUSPENSION The particulars of which are set out in Part 1 and Part 2 of the said Schedule. The authorisation is also subject to any special conditions as may be specified in the said Schedule. The authorisation, unless previously revoked, shall continue in force from 30/09/2008. Signed on behalf of the Irish Medicines Board ________________ A person authorised in that behalf by the said Board. (NOTE: From this date of effect, this authorisation replaces any previous authorisation in respect of this product which is now null and void.) IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 20/12/2008_ _CRN 7004600_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Multiject IMM Intramammary Suspension. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients, see sction 6.1. 3 PHARMACEUTICAL FORM Intramammary suspension. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Multiject IMM is indicated in the treatment of acute and subacute mastitis in lactating cows, caused by organisms sensitive to penicillin, streptomycin Прочетете целия документ